Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration’s recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma.
Science Brief thanks to EurekAlert.
Read more here:
Promising treatment for metastatic melanoma ‘fast tracked’ by FDA
Net News Publisher for Science News
Related articles by Zemanta
- ‘Co-conspirator’ Cells Could Hold Key to Melanoma Prediction, Prevention (netnewspublisher.com)
- Imaging Melanoma (netnewspublisher.com)
- Tumor Target Suggests Personalized Treatment for Melanoma (netnewspublisher.com)
